References
- Global Initiative for Chronic Obstructive Lung Disease [homepage on the Internet]Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary diseaseGlobal Initiative for Chronic Obstructive Lung Disease2015 [updated 2015]. Available from: http://www.goldcopd.org/Accessed August 27, 2015
- van EedenSFHoggJCThe response of human bone marrow to chronic cigarette smokingEur Respir J200015591592110853859
- SaettaMAirway inflammation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19991605 Pt 2S17S2010556163
- MaestrelliPSaettaMMappCEFabbriLMRemodeling in response to infection and injury airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116410 Pt 2S76S8011734472
- RennardSIInflammation and repair processes in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19991605 Pt 2S12S1610556162
- CosioMGGuerassimovAChronic obstructive pulmonary disease inflammation of small airways and lung parenchymaAm J Respir Crit Care Med19991605 Pt 2S21S2510556164
- ShapiroSDThe macrophage in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19991605 Pt 2S29S3210556166
- HillATBayleyDStockleyRAThe interrelationship of sputum inflammatory markers in patients with chronic bronchitisAm J Respir Crit Care Med1999160389389810471615
- HoggJCPathophysiology of airflow limitation in chronic obstructive pulmonary diseaseLancet2004364943570972115325838
- StockleyRANeutrophils and the pathogenesis of COPDChest20021215 suppl151S155S12010844
- OudijkEJLammersJWKoendermanLSystemic inflammation in chronic obstructive pulmonary diseaseEur Respir J Suppl200322465s13s14621102
- ThorleifssonSJMargretardottirOBGudmundssonGChronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in IcelandRespir Med2009103101548155319427181
- GanWQManSFSenthilselvanASinDDAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax200459757458015223864
- KaradagFKirdarSKarulABCeylanEThe value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary diseaseEur J Intern Med200819210410818249305
- KaradagFKarulABCildagOYilmazMOzcanHBiomarkers of systemic inflammation in stable and exacerbation phases of COPDLung2008186640340918807087
- SinDDManSFWhy are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary diseaseCirculation2003107111514151912654609
- RidkerPMRifaiNPfefferMASacksFBraunwaldELong-term effects of pravastatin on plasma concentration of C-reactive proteinCirculation1999100323023510411845
- PrueferDMakowskiJSchnellMSimvastatin inhibits inflammatory properties of Staphylococcus aureus α-toxinCirculation2002106162104211012379581
- BonnetJMcPhersonRTedguiAComparative effects of 10-mg versus 80-mg atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (comparative atorvastatin pleiotropic effects) studyClin Ther200830122298231319167589
- JialalISteinDBalisDGrundySMAdams-HuetBDevarajSEffect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein levelsCirculation2001103151933193511306519
- KinlaySSchwartzGGOlssonAGHigh-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL studyCirculation2003108131560156612975259
- AlbertMADanielsonERifaiNRidkerPMPRINCE InvestigatorsEffect of statin therapy on C-reactive protein levels. The pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort studyJAMA20012861647011434828
- BalkEMLauJGoudasLCEffects of statins on nonlipid serum markers associated with cardiovascular diseaseAnn Intern Med2003139867068214568856
- JandaSParkKFitzGeraldJEtminanMSwistonJStatins in COPD: a systematic reviewChest2009136373474319376844
- PrueferDScaliaRLeferAMSimvastatin inhibits leukocyte–endothelial cell interactions and protects against inflammatory processes in normocholesterolemic ratsArterioscler Thromb Vasc Biol199919122894290010591666
- MorimotoKJanssenWJFesslerMBLovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary diseaseImmunol20061761276577665
- HothersallEMcSharryCThomsonNCPotential therapeutic role for statins in respiratory diseaseThorax200661872973416877692
- LeeTMLinMSChangNCUsefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatinAm J Cardiol2008101453053518312772
- BandoMMiyazawaTShinoharaHOwadaTTerakadoMSugiyamaYAn epidemiological study of the effects of statin use on airflow limitation in patients with chronic obstructive pulmonary diseaseRespirology201217349349822142478
- LawesCThornleySYoungRStatin use in COPD patients is associated with a reduction in mortality: a national cohort studyPrim Care Respir J2012211354022218819
- ShengXMurphyMMacDonaldTEffect of statins on total cholesterol concentrations, cardiovascular morbidity, and all-cause mortality in chronic obstructive pulmonary disease: a population-based cohort studyClin Ther201234237438422244052
- WangMLoYTsaiCStatin use and risk of COPD exacerbation requiring hospitalizationAm J Med2013126759860623684060
- HoTWTsaiYJRuanSYIn-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based studyPLoS One2014912e11486625490399
- IngebrigtsenTMarottJNordestgaardBLangePHallasJVestboJStatin use and exacerbations in individuals with chronic obstructive pulmonary diseaseThorax2015701334025349333
- BartziokasKPapaioannouAMinasMStatins and outcome after hospitalization for COPD exacerbation: a prospective studyPulm Pharmacol Ther201124562563121729761
- HuangCCChanWLChenYCStatin use and hospitalization in patients with chronic obstructive pulmonary disease: a nationwide population based cohort study in TaiwanClin Ther201133101365137021962452
- LahousseLLothDJoosGStatins, systemic inflammation and risk of death in COPD: The Rotterdam studyPulm Pharmacol Ther201326221221723142156
- CrinerGConnettJAaronSDSimvastatin for the prevention of exacerbations in moderate to severe COPDN Engl J Med2014370232201221024836125
- NeukammAHoisethAEinvikGRosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trialJ Intern Med20152781596725495178
- CrinerGBourbeauJDiekemperRPrevention of acute exacerbations of COPD – American College of Chest Physicians and Canadian Thoracic Society GuidelineChest2015147489494225321320